DWP309008
/ Innovo Therap, Daewoong Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 14, 2026
Daewoong Pharma licenses AI-discovered IBD drug from Korea's Innovo
(Chosun Biz)
- "With this agreement, Daewoong Pharmaceutical secured exclusive worldwide rights to develop, manufacture, and commercialize INV-008"
Licensing / partnership • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1